AT1 role in serology testing, page-5

I was fortunate enough to enter pre ipo and at that stage was only HIV related .
I sold well with initial over exuberance at listing .
Was really too good not to take a quid .
( as did Walker group ) .
I still like this stock and it’s potential however I believe the market is large for their product but at this stage their manufacturing capacity needs to increase some how . This could be a dilemma for management as how much do they increase or can increase it by and without getting trapped having an oversupply ( sep if Covid19 quitens down )
Watching daily